Mutations of ACVRL1, ENG, SMAD1, SMAD4, and SMAD9 are closely related with alterations of the TGF-β/BMPR2 signal pathways in pathogenesis of primary PAH (2, 4–6). The gene discussed is SMAD9; the disease is pulmonary arterial hypertension.